CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
March 2016—Beckman Coulter Diagnostics obtained a CE mark for and released its new Access TSH (3rd IS) assay for use with the company’s Access family of immunoassay systems. This assay is the next generation of the Access Hypersensitive hTSH and Access Fast hTSH assays for the quantitative determination of human thyroid stimulating hormone (TSH, thyrotropin) levels in human serum and plasma.
The assay is standardized to the World Health Organization 3rd International Standard for human TSH (IRP 81/565), is offered in reagent pack sizes of 100 tests/pack, 200 tests/kit, and provides reliable and accurate results with an assay range that supports measuring patient samples as low as 0.005 μIU/mL. Additionally, the paramagnetic particle, chemiluminescent immunoassay was developed to reduce interferences and to deliver robust lot-to-lot performance for reproducible results.
Beckman Coulter Diagnostics, 714-993-5321